Literature DB >> 20124354

Endogenous 3,4-dihydroxyphenylalanine and dopaquinone modifications on protein tyrosine: links to mitochondrially derived oxidative stress via hydroxyl radical.

Xu Zhang1, Matthew E Monroe, Baowei Chen, Mark H Chin, Tyler H Heibeck, Athena A Schepmoes, Feng Yang, Brianne O Petritis, David G Camp, Joel G Pounds, Jon M Jacobs, Desmond J Smith, Diana J Bigelow, Richard D Smith, Wei-Jun Qian.   

Abstract

Oxidative modifications of protein tyrosines have been implicated in multiple human diseases. Among these modifications, elevations in levels of 3,4-dihydroxyphenylalanine (DOPA), a major product of hydroxyl radical addition to tyrosine, has been observed in a number of pathologies. Here we report the first proteome survey of endogenous site-specific modifications, i.e. DOPA and its further oxidation product dopaquinone in mouse brain and heart tissues. Results from LC-MS/MS analyses included 50 and 14 DOPA-modified tyrosine sites identified from brain and heart, respectively, whereas only a few nitrotyrosine-containing peptides, a more commonly studied marker of oxidative stress, were detectable, suggesting the much higher abundance for DOPA modification as compared with tyrosine nitration. Moreover, 20 and 12 dopaquinone-modified peptides were observed from brain and heart, respectively; nearly one-fourth of these peptides were also observed with DOPA modification on the same sites. For both tissues, these modifications are preferentially found in mitochondrial proteins with metal binding properties, consistent with metal-catalyzed hydroxyl radical formation from mitochondrial superoxide and hydrogen peroxide. These modifications also link to a number of mitochondrially associated and other signaling pathways. Furthermore, many of the modification sites were common sites of previously reported tyrosine phosphorylation, suggesting potential disruption of signaling pathways. Collectively, the results suggest that these modifications are linked with mitochondrially derived oxidative stress and may serve as sensitive markers for disease pathologies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124354      PMCID: PMC2877980          DOI: 10.1074/mcp.M900321-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  60 in total

Review 1.  Energy transduction: proton transfer through the respiratory complexes.

Authors:  Jonathan P Hosler; Shelagh Ferguson-Miller; Denise A Mills
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

2.  Optimization and use of peptide mass measurement accuracy in shotgun proteomics.

Authors:  Wilhelm Haas; Brendan K Faherty; Scott A Gerber; Joshua E Elias; Sean A Beausoleil; Corey E Bakalarski; Xue Li; Judit Villén; Steven P Gygi
Journal:  Mol Cell Proteomics       Date:  2006-04-23       Impact factor: 5.911

3.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.

Authors:  Joshua E Elias; Steven P Gygi
Journal:  Nat Methods       Date:  2007-03       Impact factor: 28.547

Review 4.  Metal Ion availability in mitochondria.

Authors:  Fabien Pierrel; Paul A Cobine; Dennis R Winge
Journal:  Biometals       Date:  2007-01-16       Impact factor: 2.949

Review 5.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

Review 6.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 7.  Protein-bound 3,4-dihydroxy-phenylanine (DOPA), a redox-active product of protein oxidation, as a trigger for antioxidant defences.

Authors:  Michelle Nelson; A Ruth Foxwell; Peter Tyrer; Roger T Dean
Journal:  Int J Biochem Cell Biol       Date:  2006-10-07       Impact factor: 5.085

8.  A method for selective enrichment and analysis of nitrotyrosine-containing peptides in complex proteome samples.

Authors:  Qibin Zhang; Wei-Jun Qian; Tatyana V Knyushko; Therese R W Clauss; Samuel O Purvine; Ronald J Moore; Colette A Sacksteder; Mark H Chin; Desmond J Smith; David G Camp; Diana J Bigelow; Richard D Smith
Journal:  J Proteome Res       Date:  2007-05-12       Impact factor: 4.466

9.  Targeting HSP90 to halt neurodegeneration.

Authors:  Kathleen A Gallo
Journal:  Chem Biol       Date:  2006-02

10.  Unbiased identification of cysteine S-nitrosylation sites on proteins.

Authors:  Behrad Derakhshan; Pamela C Wille; Steven S Gross
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

View more
  6 in total

Review 1.  Tyrosine modifications in aging.

Authors:  Maria B Feeney; Christian Schöneich
Journal:  Antioxid Redox Signal       Date:  2012-05-14       Impact factor: 8.401

2.  NADPH oxidase-derived H2O2 subverts pathogen signaling by oxidative phosphotyrosine conversion to PB-DOPA.

Authors:  Luis A Alvarez; Lidija Kovačič; Javier Rodríguez; Jan-Hendrik Gosemann; Malgorzata Kubica; Gratiela G Pircalabioru; Florian Friedmacher; Ada Cean; Alina Ghişe; Mihai B Sărăndan; Prem Puri; Simon Daff; Erika Plettner; Alex von Kriegsheim; Billy Bourke; Ulla G Knaus
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-25       Impact factor: 11.205

Review 3.  Proteomic approaches to analyze protein tyrosine nitration.

Authors:  Maria B Feeney; Christian Schöneich
Journal:  Antioxid Redox Signal       Date:  2013-01-03       Impact factor: 8.401

Review 4.  Oxidative stress and the HIV-infected brain proteome.

Authors:  Lerna Uzasci; Avindra Nath; Robert Cotter
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-09       Impact factor: 4.147

5.  Plasmodium vivax trophozoite-stage proteomes.

Authors:  D C Anderson; Stacey A Lapp; Sheila Akinyi; Esmeralda V S Meyer; John W Barnwell; Cindy Korir-Morrison; Mary R Galinski
Journal:  J Proteomics       Date:  2014-12-27       Impact factor: 4.044

Review 6.  Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms.

Authors:  Anindita Bose; Gregory A Petsko; David Eliezer
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.